PDB18 COST OFFSETS ASSOCIATED WITH USE OF EXENATIDE COMPARED TO GLARGINE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74996-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)74996-2/fulltext
Title :
PDB18 COST OFFSETS ASSOCIATED WITH USE OF EXENATIDE COMPARED TO GLARGINE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74996-2&doi=10.1016/S1098-3015(10)74996-2
First page :
Section Title :
Open access? :
No
Section Order :
918